ReviewAnnals of the New York Academy of Sciences2018

Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.

Shaohua Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.